Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL5516 Target Snapshot

Lysophosphatidylserine lipase ABHD12 · SINGLE PROTEIN · Homo sapiens

156Compounds
35Assays
2Approved Drugs
48.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q8N2K0. Use UniProt Q8N2K0 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q8N2K0 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Lysophosphatidylserine lipase ABHD12 as ChEMBL target CHEMBL5516, mapped to UniProt Q8N2K0. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Lysophosphatidylserine lipase ABHD12
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL5516
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q8N2K0
Lysophosphatidylserine lipase ABHD12
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Lysophosphatidylserine lipase ABHD12 is the right protein anchor across sources, using UniProt Q8N2K0 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelLysophosphatidylserine lipase ABHD12
UniProt AccessionQ8N2K0
Component TypeProtein
Sequence Length398 aa

Lysophosphatidylserine lipase ABHD12

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Lysophosphatidylserine lipase ABHD12, mapped to UniProt Q8N2K0. Sequence length is 398 aa.

Mapped IDQ8N2K0
Review nameLysophosphatidylserine lipase ABHD12
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

2
Approved
Assay Mix

Activity Type Distribution

IC5047.0
KD1.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL175247 7.1 IC50 80.0 Approved
CHEMBL4757488 6.22 IC50 600.0 Preclinical
CHEMBL4164954 5.68 IC50 2100.0 Preclinical
CHEMBL4780771 5.68 IC50 2100.0 Preclinical
CHEMBL4167303 5.6 IC50 2500.0 Preclinical
CHEMBL5653589 4.98 Kd 10463.58 Preclinical
CHEMBL465 4.94 IC50 11600.0 Approved
CHEMBL4845760 4.85 IC50 14100.0 Preclinical
CHEMBL4862731 4.54 IC50 28800.0 Preclinical
Distribution

pChEMBL Value Distribution

0
5.0
3
5.5
1
6.0
4
6.5
1
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

ORLISTAT
CHEMBL175247
Approved 1998
Assay Landscape

Assay Landscape

35
Total Assays
9
Tested Compounds
3
Assay Types
Binding — 31 assays, 9 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 21 8 6.0
assay format 8 0
single protein format 2 1 5.0
Toxicity — 3 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 3 0
ADME — 1 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine